The most predictive CpG is hypo-methylated in the future-NHL/high-epiTOC group and located in CpGs islands and targets the gene VGLL3, which is known to be involved in tumor cell proliferation25 associated with future-NHL/high-epiTOC NHL group. This evidence concerns the gene VGLL3 and non-Hodgkin lymphoma.